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Objectives – The frequency of cognitive difficulties in childhood cancer survivors varies according 
to the measurement strategy. The goal of this research is to (1) describe agreements and 
differences between measures of working memory and attention (2) identify contributors of 
these differences, such as emotional distress, affects, and fatigue.  
Methods – We used data available for 138 adults successfully treated for childhood acute 
lymphoblastic leukemia (ALL) (PETALE cohort). Working memory and attention were assessed 
using subtests from the WAIS-IV and self-reported questionnaires (BRIEF-SR and CAARS-S:L). 
Potential contributors included emotional distress, anxiety, depression (BSI-18), affects (PANAS), 
and fatigue (PedsQL-MFS). We explored measurement agreements and differences using 
diagnostic indices and multivariate regression models. 
Results – The frequencies of working memory and attention deficits were higher when using 
cognitive tests (15-21%) than with self-reports (10-11%). Self-reported questionnaires showed 
high specificity (median 0.87) and low sensitivity (median 0.10) suggesting they did not reliably 
identify positive cases on cognitive tests. We identified negative affectivity as a possible 
contributor to inconsistencies between self-report and test results.  
Conclusions – When measuring working memory and attention in childhood ALL survivors, 
cognitive test results and self-reports should not be considered equivalent. At best, self-report 
may be used for screening (high specificity), but not to assess prevalence in large samples. Self-
reported difficulties are also probably influenced by negative mood in this population. 
 





Therapy advances have led to an increase of the 5-year survival rate of childhood Acute 
Lymphoblastic Leukemia (ALL) reaching 91%1. However, about half of the  ALL survivors develop 
at least one clinically significant long-term cognitive sequelae2. In addition to the type and 
intensity of treatment,  risk factors known to increase the risk of cognitive difficulties include 
female sex, early age at diagnosis (≤ 5 years), and some genetic characteristics3,4.  
Various studies have shown that ALL survivors who received chemotherapy, combined or not with 
cranial radiotherapy (CRT), have a lower overall intellectual potential (6-8 IQ points lower) than a 
healthy population5,6. The most commonly observed cognitive deficits in survivors are a limited 
attention span, working memory and information processing speed2,5,7. These deficits become 
more obvious 2-7 years after the end of treatment5,8 and should be routinely evaluated as they 
affect academic performance and quality of life3,9. 
It is common practice in oncology research to consider self-reported questionnaires as reliable 
tools to assess the frequencies of cognitive late-effects10. However, recent studies have reported 
limited correlations between tested and self-reported cognitive difficulties11,12. First, cognitive 
tests may have limited ecological validity12. Considering that cognitive tests are usually taken in 
environments free of distractions and stressors, we could expect that more cognitive difficulties 
be self-reported than tested. Second, studies have pointed to the tendency to normalize one’s 
own experience that could downplay the self-report of one’s own difficulties13. Finally, some 
studies in adult cancer suggest that intensity of symptoms in self-reported cognitive assessment 
is associated with negative mood11,12, anxious and depressive symptoms11,14, and fatigue14, but 
no such study is yet available in the context of pediatric cancer. It is also widely recognized that 
depressive and anxious symptoms, depending on their subtype and severity, may negatively 
impact cognitive performance15,16. 
The few studies that have used both types of cognitive measures in pediatric cancer survivors8,17 
have found more frequent deficits when tested than when self-reported, on attention (30% vs. 
10%) and working memory (59% vs. 28%)8,17, suggesting method concordance issues. Although 
these two cognitive domains are key in understanding the cascade of cognitive deficits in this 
population, no study has yet attempted to explain these differences empirically. In this study, we 
will refer to two types of concordance or inconsistency: agreement refers to relative agreement 
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measured by correlation, and differences refer to absolute agreement measured by raw 
difference. 
The first aim of the current study was to provide a detailed description of agreements and 
differences between measurement strategies in the domains of attention and working memory, 
amongst individuals who were successfully treated for childhood ALL. The second aim was to 
explore the contributing role of emotional status, characterized by emotional distress, depression 




The sample was composed of individuals who had been successfully treated for ALL (PETALE 
cohort) at the Sainte-Justine University Health Centre (SJUHC) or Quebec University Health Centre 
(QUHC). A detailed description of the methodology for cohort recruitment and characterization 
can be found in another article18. The inclusion criteria were: 1)  diagnosis of ALL prior 19 years, 
2) treatment per Dana Farber Cancer Institute (DFCI)  protocol, 3) more than 5 years post diagnosis 
and 4) no relapse or transplantation. A total of 374 survivors aged between 13 and 40 were 
contacted to participate in this study (Flow chart, Figure 1). The sample of the current study 
consists of 138 survivors aged 19 and older for whom both the cognitive tests and self-reported 
questionnaires were available (participation 84%, completion 75%) (Table 1). We used data from 
adult participants only, to warrant that status was not reported by a parent. The study protocol 
was approved by the Research Ethics Board at both sites (SJUHC: #2013-479; QUHC: #MP-20-
2015-2176). When comparing the group completing testing (N=138) with those for whom data 
was incomplete (N=47), we found the study group to be older at study time (p=0.003), older at 
diagnosis (p=0.032), treated with less recent DFCI protocols (p=0.033), with higher frequency of 
high risk status (p=0.013), but no difference on sex, or use of radiotherapy. 
Procedure 
The data were collected as part of a study on the biomarkers of the long-term effects of the ALL 
at the SJUHC and QUHC18. Patients were contacted by phone by a research nurse who told them 
about the study. They subsequently gave their informed written consent by reading and signing a 
consent form they received by mail. On site, participants took part in a short neuropsychological 
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assessment (cognitive tests: 30 minutes) followed by self-reported cognitive and affective 
questionnaires (45 minutes). Tests and self-reports were selected based on previous use in similar 
populations, suggesting domains overlap8,17. Participants’ detailed clinical history was collected 
from their medical records.  
 
Measures 
Test-based cognitive measures 
The cognitive test battery included subtests from the Weschler Adult Intelligence Scale – 4th 
edition – French Canadian version (WAIS-IV)19. To assess working memory, we used the Working 
Memory Index (WMI) from the WAIS-IV. As this may be confounded with attention, we also used 
the Letter-Number Sequencing (LNS) subtest. To assess attention independently of working 
memory, we used the score of the Digit Span Forward condition (DSF) from the Digit Span 
subtest20. These were selected on strong theoretical bases, but it must be noted that indices (e.g. 
WMI) are aggregate measures generally more reliable than subtests (e.g. LNS) or conditions (e.g. 
DSF) on cognitive performance tests19. 
Self-reported cognitive measures 
Standardized self-administered cognitive questionnaires were used. To assess working memory 
difficulties, we used the Working Memory Scale (WMS) from the adult version of the Behavior 
Rating Inventory of Executive Function (BRIEF-SR)21. The BRIEF-SR is a standardized questionnaire 
evaluating adults’ executive functions and self-regulation in their daily lives over the last six 
months. The scale measures one’s ability to retain information when performing a task, coding 
information, or generating goals or plans in a sequential manner (i.e., “Forgets what he/she was 
doing,” “When sent to get something, forgets what he/she is supposed to get”). The scale is 
composed of 8 items that can be rated from 0 (never) to 2 (often). Its internal consistency was 
satisfactory (α=.80). To assess self-reported attention difficulties, we used the Inattention 
Symptoms Scale (ISS) from the self-administered long version of the Conners Adult ADHD Rating 
Scale (CAARS-S:L)22. The CAARS-S:L is a standardized questionnaire evaluating the presence and 
intensity of the symptoms associated with attention deficit with or without hyperactivity. The 
scale is composed of 9 items rated from 0 (never) to 3 (very often) (α=.88), such as “Inattentive, 
easily distracted”. For both self-reported questionnaires, the percentile scale scores were reverse 






To assess the presence and intensity of general distress, depression, and anxiety symptoms over 
the last 7 days, the Brief Symptom Inventory (BSI-18) was used. The BSI-18 is composed of 18 
items scored on a scale ranging from 0 (not at all) to 4 (very much). We used three scales from 
the BSI-18. The general distress index consists of 18 items and includes depressive, anxious, and 
somatic symptoms (α=0.89). The depression index consists of 6 items and refers to feelings of 
loneliness, anxiety, depreciation, and despair (α=0.81). The anxiety index consists of 6 items and 
refers to feelings of nervousness, tension, agitation, and fear (α=0.80). We used T scores, and cut-
points from the original manual to determine cases on general distress (2 indices ≥63 or total ≥63), 
anxiety (≥63), and depression (≥63)23. To assess participants’ overall presentation of affects over 
the last two weeks, we used the Positive and Negative Affect Schedule (PANAS)24. The PANAS 
includes two scores (ranging from 0 to 50), each consisting of 10 items scored on a scale ranging 
from 1 (not at all) to 5 (extremely). The first score indicates the level of negative affect (i.e., to feel 
“anxious,” “angry”, α=0.81) whereas the second indicates the level of positive affect (i.e., to feel 
“interested,” “excited”, α=0.80). Participants’ level of fatigue was determined with the Pediatric 
Quality of Life Multidimensional Fatigue Scale, Standard version, Young adult report (PedsQL-
MFS)25. To avoid spurious overlaps with cognitive complaints, only the general fatigue index 
(ranging from 0 to 100) was used. The scale includes physical fatigue and activity level (i.e., “I feel 
too tired to do things that I like to do”; α=0.91). This index consists of 6 items scored on a scale 
ranging from 0 (not at all a problem) to 4 (a lot of problem) that are then recoded to specific 
percent values (0=100 to 4=0). The final scores were reverse coded, with higher scores indicating 
a higher level of general fatigue.  
Statistical analyses  
Preliminary analyses  
Given age variability in the study sample, we used standard and percentile scores to describe 
cognitive functioning. We sought to optimize the level of concordance between test and self-
reported measures by computing sensitivity, specificity, agreement rate using three thresholds 
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commonly used in cognitive functioning measures (-1.0SD, -1.2SD and -1.5SD). To evaluate 
agreement, we computed Pearson’s correlations between measures.  
Main analyses  
For the first aim of the study, we computed rank differences based on within sample z scores for 
both cognitive tested and self-reported elements using the formula: D=(tested z-score)-(self-
reported z-score). This difference was calculated for both cognitive domains of interest in this 
study. From here onwards, the differences observed between these measures will be referred to 
as, for working memory: WMI-WMS, LNS-WMS, and for attention: DSF-ISS. For the second aim of 
the study, we first established normality of these differences, and conducted three linear 
regression models in which each difference was in turn the dependent variable. The independent 
variables were: general distress, depression, anxiety, positive affects, negative affects, and 
general fatigue. Models were adjusted for age and gender to account for higher cognitive deficit 
frequency in older individuals and women. Although socioeconomic status may be an important 
factor, we could not adjust models as missing information affected 22% of the study sample. Post-
hoc bivariate mean comparisons and non-parametric correlations suggested no association 
between education level and difference scores (ρ=0.13-0.16, p>0.19).  
Data availability statement 





On test measures, the sample showed overall working memory or attention deficits with mean 
percentiles of WMI=29.02 ± 26.16, LNS=32.69 ± 25.76, DSF: 30.62 ± 25.33 (all p values<0.001 when 
comparing with a median of 50). The sample included a higher proportion of participants with 
clinically significant deficits (-1.5SD) on working memory (respectively 16% and 15% vs. 9% in 
norms) and attention (21% vs. 9%). In sharp contrast, on self-report measures, participants did 
not report greater working memory or attention deficits, with mean percentiles of WMS: M=47.93 
± 27.99 and ISS: M=56.59 ± 31.79 (p>0.53). Clinically significant difficulties in working memory 




Compared to the general population (T=50), survivors reported similar general distress (M=49.82 
± 9.17), depressive symptoms (M=48.62 ± 8.72), or anxious symptoms (M=48.70 ± 9.46). They 
reported more intense positive than negative affect (M=33.77 ± 5.17 vs 18.15 ± 5.50, p<0.001). 
Participants’ perceived general fatigue was also heterogeneous, with a coefficient of variation 
SD/M of 89% within the sample (M=23.67 ± 20.98; Table S1). 
Preliminary analyses  
The most favorable clinical cutpoints optimizing agreement rates between tested and self-
reported measures were set at -1.5 SD (WMI-WMS, LNS-WMS et DSF-ISS; Figure 2). The 
specificity/sensitivity imbalance indicated that self-reported measures reliably identified true 
negatives (median specificity = 0.87), but did not identify true positives, i.e. participants 
presenting actual difficulties on cognitive tests (median sensitivity = 0.10). When exploring 
intercorrelations, we found cognitive test measures to be weakly associated with self-reported 
cognitive functioning on memory (WMI and WMS: r=0.208, p=0.024; LNS and WMS: r=0.175, 
p=0.040) but not attention (DSF and ISS: r=0.047, p=0.592). We found cognitive test measures to 
be basically uncorrelated with emotional distress and affectivity (median r: WMI: -0.033; LNS: 
0.001; DSF: -0.066). In contrast, self-reported cognitive measures were largely associated with 
these domains (median r = WMS: -0.409; CAARS-S:L: -0.539) (Table S2). 
Main analyses  
Upon analyzing rank differences between tested and self-reported results for the two domains, 
all distributions appeared unbiased and centered, suggesting an absence of a systematic pattern 
in favor of “underestimation” or “overestimation” of difficulties, with medians of rank differences 
of WMI-WMS=0.12, LNS-WMS=-0.50 and DSS-ISS=0.07. For further use in multivariate models, 
we found a reasonable fit with the normal distribution (Kurtosis = -0.04-0.35, Skewness = 0.19-
0.60, Q-Q plots, Kolmogorov-Smirnov tests with p ≥ 0.20 and Shapiro-Wilk tests with p ≥ 0.11) 
(Figure 3).  
When analyzing the potential contributors of the differences between tested and self-reported 
cognitive abilities, we found a larger negative affectivity to be associated with differences, 
suggesting an imbalance in favor of larger self-reported than tested difficulties. For working 
memory (WMI), the differences were not associated with emotional factors. However, using a 
subtest independent of the attention domain (LNS), the differences were significantly associated 
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with increased negative affects (β=0.066; p=0.023). The results were similar for attention, with a 
potential contribution of negative affect (β=0.087; p=0.005). For both domains, differences were 
not associated with age, gender, distress, depression, anxiety, or general fatigue (p>.120; 
Table S3). 
Discussion 
In a cross-sectional study involving 138 childhood ALL adult survivors, we found important 
inconsistencies between working memory and attention measures. We identified negative affect 
as a probable contributing factor to the imbalance of self-reported over tested difficulties.  
With respect to their cognitive profile, participants’ performance on standardized tests assessing 
working memory and attention appears similar to that found in a recent meta-analysis (M=-0,5 
SD)5. The rate of significant deficits 15-21% was twice that of the general population, consistent 
with the observation that the two cognitive domains of working memory and attention are 
particularly affected in childhood ALL survivors5,7. In comparison, self-reported questionnaires 
yielded frequencies of around 10%, again similar to previous studies using the same assessment 
strategy10,26,27. These findings suggest that studies using exclusively self-reported questionnaires, 
such as several large-scale studies10,27, could underestimate the frequency of neurocognitive late 
effects. Differences in measurement strategy could also explain the large range of frequencies 
found in the literature. We also found that, in the context of pediatric oncology, cognitive 
questionnaires were specific but not sensitive28. Consequently, self-reported questionnaires 
would not be recommended to assess positive cases, but rather would be recommended to 
discard negative cases. When used alone, these questionnaires should not be considered as a 
valid approach to assess the  neuropsychological status and should probably not be used to derive 
prevalence in population-based studies. Because neuropsychological evaluations are long and 
costly, further research should refine alternative strategies, such as developing online versions of 
short neuropsychological screening tools29, or improving screening technology using stepwise 
approaches30. 
One plausible hypothesis to explain such apparent inconsistency between methods calls for a 
general tendency of normalizing their difficulties among survivors, when describing their own 
functioning31. Consistent with this, we found that their mean self-reported negative affect was 
about half the size of their self-reported positive affect. The rate of participants with significant 
affective symptoms was also similar to the general population, and the overall portrait of the 
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group was even more positive than in comparable samples31,32. This predominance of positive 
affect was observed here in a group of young adults. Previous research have shown that 
psychological symptoms and negative mood increase during adulthood, as participants face 
responsibilities, and physical sequelae become more explicit33. 
In our study, we did not identify a systematic pattern toward a clear imbalance between self-
reported and cognitive-tested issues. Consequently, there was no tendency to “overestimate” or 
“underestimate” one’s difficulties. In subsequent analyses aiming at explaining differences 
between measures, we found that only a high level of negative affect, among several other 
psychological factors (distress, depression, anxiety, and fatigue), could partially explain this 
phenomenon. Although statistical models only explained a small share of variance, this finding 
highlights the importance of considering negative affect or mood, when interpreting self-report12. 
This observation is consistent with a larger literature on the role of self-reported status in the 
discrepancy between cognitive tests and questionnaires, across different conditions, in normal 
controls, and across the lifespan, such as attention disorders, and multiple sclerosis34.  
We found that participants’ self-reported cognitive difficulties were more closely related to their 
self-reported affect than to their results on standardized tests35, suggesting methodological 
variance. Similar findings have been observed in other clinical populations, including in neurology 
or psychiatry36,37, suggesting methodological variance is a robust finding and affect pediatric 
oncology in a similar way as other clinical domains. It is probable that the questionnaires assessed 
less the cognitive status than the individual perception of cognitive abilities and functioning. Sad, 
tensed, or angry participants would be more likely to focus on their cognitive failures and to 
perceive their cognitive “impairment” as more severe. This could even increase their feelings of 
sadness, tension, or anger.38 Finally, whereas frequencies of cognitive difficuties are 
systematically higher in girls/women due to cerebral specificities, we did not find that sex was 
related with differences between test-based and self-reported cognitive difficulties, consistent 
with previous analyses performed in the PETALE cohort39.  
Clinical Implications 
Our findings suggest that self-reported cognitive questionnaires should not be used to assess the 
presence of cognitive deficits and derive frequencies in large-scale studies. Corrective procedures 
or improved screening tools may be elaborated in the future to address this issue. In addition, 
cognitive tests and self-reports probably do not measure the same type of cognitive activity12. As 
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cognitive self-report may be vulnerable to deteriorated mood, it could be useful to control for 
mood in surveys evaluating cognitive deficits with self-reports.  
Study limitations 
First, our findings reflect the experience of a selected sample of young adult survivors of ALL at a 
specific time. We must recognize the selection bias of older age at study time and at diagnosis, 
although it is unclear how this may impact the results, as anteriority was confounded with 
treatment toxicity and risk status. Thus, the results might not be generalized to any ALL sample or 
survivors of other types of cancer or participants at other time points along their trajectory. 
Second, it should be noted that it is hard to find equivalent domains in both types of measures 
(test and self-reports). For instance it was more difficult to clearly distinguish working memory 
and attention among self-reported questionnaires than among standardized tests, which could 
represent a bias in the study. Finally, a large proportion of the observed difference between 
methods still remain unexplained, as the contributors considered here explained only 14-22% of 
the inconsistency variance. Future research should include other factors that might influence 
cognitive assessment in this population, such as socioeconomic status and coping styles40.  
Conclusions 
In conclusion, our study of 138 adult survivors of childhood ALL suggested that deficits in working 
memory and attention were more frequent when assessed by standardized tests than self-
reports. Yet, we found no systematic tendency to overreport or underreport one’s difficulties. The 
study identified negative affect as a factor of imbalance between measurement strategies, 
favoring higher self-reported cognitive difficulties. Future research should recognize that, in 
survivors of childhood cancer, tested and self-reported cognitive assessments cannot be 
considered interchangeably. It is likely that the information reported by childhood cancer 
survivors depends on a variety of factors, including their emotional status. 
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Table 1. Sample description of 138 pediatric ALL adult survivors (> 19 years) from two DFCI sites in Quebec, 
Canada 
Participants’ characteristics Total Sample 
(N=138) 
M (SD) or N (%) 
St-Justine UHC 
(N=122) 
M (SD) or N (%) 
Laval UHC 
(N=16) 




    
Sex 
    Male 













Age at follow up, years  25.91 (4.75)  26.20 (4.90)   25.13 (3.50) p=.601 
Marital Status 
    Single/Divorced 














    Caucasian 













    Pre-high school 
    High school 
    Graduate/PEDa 
    Pre-universitaryb 

























First language  
    French 
    English 















Clinical characteristics       
 
Age at diagnosis, years 7.89 (5.01) 7.97 (5.11) 7.31 (4.31) p=.849 
Time since diagnosis 18.02 (6.35) 18.05 (6.64) 17.81 (3.50) p=.915 
Radiotherapy 
    Yes 













ALL risk status 
    Standard 














    DFCI 87-01 
    DFCI 91-01 
    DFCI 95-01 
    DFCI 2000-01 

























a PED, professional education diploma. b Pre-universitary or professional diploma is a first stage of higher education 
specific to the province of Quebec, Canada, and lasts 2 or 3 years. c Description of treatment protocol strategy 
available in: Silverman et al. Leukemia. 2010;24(2):320-334. d Due to the small sample at Laval UHC, comparisons 









Figure 1.  
 
Figure 2. 
Red line = -1.5 SD, Green line= -1.2 SD, Blue line= -1.0 SD 
Note. Panel A Test measure of working memory is WMI (WAIS-IV) and self-report measure of working memory is WMS 
(BRIEF-SR). Panel B Test measure of working memory is L-N (WAIS-IV) and self-report measure of working memory is 
WMS (BRIEF-SR). Panel C Test measure of attention is DSF (WAIS-IV) and self-report measure of attention is ISS (CAARS-
S:L). Agreement = TP+TN/total, Sensitivity = TP/(TP+FN), and Specificity = TN/(TN+FP), where TP=true positives, FP=false 
positives, TN=true negatives and FN=false negatives. 
 
Figure 3. 
Note. Distribution A describes the differences between sample Z scores of WMI (WAIS-IV) and WMS (BRIEF-A), 
Distribution B between L-N (WAIS-IV) and WMS (BRIEF-A), Distribution C between DSF (WAIS-IV) and ISS (CAARS-S:L). 









Flow chart for cognitive and psychosocial description of ALL survivors  
 




58 declined to participate 
7 excluded (exclusion 
criteria) 















185 ALL adult survivors (19+ years)  
 






47 missing data 
- 43 did not return self-report 

























Test measure -1.5 SD
Self-report measure -1.5 SD
Se = 0.16  (0.02-0.30)
Sp = 0.88 (0.82-0.95)
Agreement = 0.73
Optimal cut-points
Test measure -1.5 SD
Self-report measure -1.5 SD
Se = 0.10 (-0.03-0.22)
Sp = 0.88 (0.10-0.88)
Agreement = 0.76
Optimal cut-points
Test measure -1.5 SD
Self-report measure -1.5 SD
Se = 0.05 (-0.04-0.13)
Sp = 0.88 (0.82-0.94)
Agreement = 0.75
Figure 3. Box plot display of inconsistencies between test measures and self-report measures on working 













Supplementary Table S1.  
Description of working memory and attention difficulties evaluated by cognitive test and self-report 
measures, and affective status in a sample of 138 pediatric ALL adult survivors 
Measures  Mean (SD) Frequency below 
 cutpoint N (%)† 
Cognitive measures     
WAIS-IV percentile 





     Letter-Number Sequencing  32.69 (25.76) 21 (15.3)a 
     Digit Span Forward  29.02 (26.16) 25 (21.1)a 
 
BRIEF-SR percentile 















   
BSI-18 T-score   
     General distress 49.82 (9.17) 14 (10.15)b 
     Depression 48.62 (8.72) 13 (9.42)c 
     Anxiety 48.70 (9.46) 12 (8.69)c 
     Somatization 50.95 (8.89) 21 (15.30)c 
PANAS (raw score) 




     Negative affects  18.15 (5.50)  
PedsQL-MFS (raw score) 




Note. †The frequency in a normative sample is approximately 9% (normal distribution) 
a 
Cut-point = -1.5 SD  
b Standard algorithm for determining positivity from the BSI-18 manual 
c Cut-point = 63T score for Depression, Anxiety and Somatization 
WAIS-IV: Wechsler Adult Intelligence Scale Fourth Edition; BRIEF-SR: Behavior Rating Inventory of Executive 
Function, Adult version; CAARS-S:L: Conners Adult ADHD Rating Scale, Self-report, Long version; PANAS: 
Positive and Negative affect Schedule; PedsQL: Pediatric Quality of Life Multidimensional Fatigue Scale, 




Supplementary Table S2.  
Pearson correlations between cognitive test measures, cognitive self-report measures, and self-report affective status in 
a sample of 138 pediatric ALL adult survivors  
*p<0.05, **p<0.01, ***p<0.001 
 
 1 2 3 4 5 6 7 8 9 10 11 
1. Working Memory Index 
(WAIS-IV) 
 
1.00           
2. Letter-Number (WAIS-IV) 
 
0.899*** 1.00          
3. DigitSpan Forward (WAIS-
IV) 
 
0.737*** 0.518*** 1.00         
4. Workig Memory Scale 
(BRIEF-SR) 
 
0.208* 0.175* 0.116 1.00        
5. Inattention Symptom Scale 
(CAARS:S-L) 
0.125 0.044 0.047 0.735*** 1.00       
6. General Distress, (BSI-18) 
 
-0.084 -0.064 -0.085 -0.430*** -0.575*** 1.00      
7. Anxiety (BSI-18) 
 
-0.027 0.017 -0.043 -0.399*** -0.515*** 0.830*** 1.00     
8. Depression (BSI-18) 
 
-0.039 -0.015 -0.090 -0.310*** -0.512*** 0.779*** 0.779*** 1.00    
9. Negative Affect (PANAS) 
 
-0.026 -0.045 -0.009 -0.418*** -0.589*** 0.672*** 0.651*** 0.618*** 1.00   
10. Positive Affect (PANAS) 
 
-0.005 0.045 -0.046 0.161 0.312*** -0.267** -0.135 -0.321*** -0.189* 1.00  
11. General fatigue (PedsQL) 
 
-0.101 -0.052 -0.093 -0.470 -0.582*** 0.725*** 0.624*** 0.622*** 0.642*** -0.323*** 1.00 
Supplementary Table S3.  
Summary of multiple regression models predicting inconsistencies between cognitive test measures and 
self-report measures in domains of working memory and attention difficulties in a sample of 138 pediatric 
ALL adult survivors  
Models B Std Error  




    Age 
    Sex 
Block 2 
    Positive affect (PANAS) 
    Negative affect (PANAS) 
    General distress (BSI-18) 
    Depression (BSI-18) 
    Anxiety (BSI-18) 
    General Fatigue (PedsQL) 
   
-.003 
   .232 
 
 
  -.027 
     .058 
  -.015 
  -.003 
   .021                  
   .005 
 

























    Age 
    Sex 
Block 2 
    Positive affect (PANAS) 
    Negative affect (PANAS) 
    General distress (BSI-18) 
    Depression (BSI-18) 
    Anxiety (BSI-18) 
    General Fatigue (PedsQL) 
 
-.022          




             .066 
-.018 
  .001 
  .012     



























    Age 
    Sex   
Block 2 
    Positive affect (PANAS) 
    Negative affect (PANAS) 
    General distress (BSI-18) 
    Depression (BSI-18) 
    Anxiety (BSI-18) 
    General Fatigue (PedsQL) 
  
 -.022 
   .371 
    -.044 
   .087 
   .009 
  -.010 
   .007 



















Note. Inconsistencies are measured as differences between z-scores in tested and self-reported measures. For Model 
A we used the inconsistency between WMI (WAIS-IV) and WMS (BRIEF-A). For Model B we used the inconsistency 
between L-N (WAIS-IV) and WMS (BRIEF-SR). For Model C we used the inconsistency between DSF (WAIS-IV) and ISS 
(CAARS-S:L). 
For model A, contribution ΔR2 were: Block 1= .002, Block 2= .143. Total model F= 2.278*   R2= .081 
For model B, contribution ΔR2  were: Block 1=.012, Block 2= .164. Total model F= 3.406*   R2= .125 
For model C, contribution ΔR2 were: Block 1= .015, Block 2= .217. Total model F= 4.628** R2= .181 
*p < 0.05 
**p < 0.01 
 
